Effects of a Self-Regulation Based E-MOTE Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: E-MOTE group.
- Who it may be relevant to
- Registry conditions: Nursing, Gynecological Cancers, Psycho-Oncology. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of a Self-Regulation-Based E-MOTE Emotional Care Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients From Surgery to 6-Month Post-Discharge
Overview
To evaluate the effectiveness of the E-MOTE Emotional Care Program, delivered through the Kebbi robot and the LINE Official Account, for patients newly diagnosed with gynecologic cancer undergoing surgery. The primary outcomes are psychological distress , and the secondary outcomes are physical symptoms, stress index, and quality of life.
Interventions
- Other E-MOTE group
Participants in the experimental group will receive the E-MOTE program during hospitalization on the day before surgery, postoperative day 1, and postoperative day 2 via the AI robot. The intervention includes an emotional assessment, followed by dialogue modules tailored to the participant's level of emotional distress, emotion-generated empathetic conversations, a self-affirmation relaxation training session, and a Q\&A session. After discharge, participants will continue to receive the E-MOTE
Primary outcome measures
- Distress [Time frame: Measurements will be taken before the intervention, three days after surgery, and one week after discharge.]
- Depression [Time frame: Measurements will be taken before the intervention, three days after surgery, and one week after discharge]
Secondary outcome measures (3)
- Quality of Life Measurement [Time frame: Measurements will be taken before the intervention, three days after surgery, and one week after discharge]
- Symptom Severity [Time frame: Measurements will be taken before the intervention, three days after surgery, and one week after discharge]
- Stress Index [Time frame: Measurements will be taken before the intervention, three days after surgery, and one week after discharge]
Eligibility criteria
\*\*\*Patients\*\*\*
Inclusion criteria
- Aged 18 years or older.
- Diagnosed with gynecologic cancer and undergoing surgery.
- Willing to receive E-MOTE robot and wear a smart wearable device.
- Willing to complete pre-test and post-test questionnaires.
Exclusion criteria
- Unable to communicate clearly.
- Unwilling or unable to participate in the study in its entirety.
\*\*\*Nurse\*\*\*
Inclusion criteria
- Aged 18 years or older.
- As a clinical nurse and has cared for patients who received the E-MOTE robot
Exclusion criteria
\- Unwilling to participate in the qualitative interview.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Supportive care
Study locations
Taiwan · 1 center
- National Taiwan University — Taipei
Identifiers
NCT: NCT07745478 · 202602068RINC